Illuminate celebrates five year milestone
Illuminate celebrates its 5-year anniversary operating in Australia on Australian and international projects!
Illuminate RED reaches over 10 subscribing companies
Since its launch in late 2017, there are now more than 10 subscribing pharmaceutical companies using Illuminate RED.
One of our earliest subscribing companies has this to say about Illuminate RED:
“The ease and flexibility of being able to download and combine various data sets and graphically present this, has made communicating complex data to the leadership team much easier.”
Illuminate moves to virtual office!
Post COVID-19, Illuminate has moved to a virtual office. You can still find us here or in the ‘contact us’ section.
New price calculator
Illuminate has launched a new free online tool to help people calculate PBS ex manufacturers prices from dispended prices and vice versa.
Illuminate complete modelling to help determine prices for a leading global vaccine under development
This innovative work involved building several cost utility models to determine the threshold price in a range of large international markets. The vaccine is a leader in the therapeutic field. Peter also has attended the US advisory board meeting as the representative Health Economists to advise on the Phase 3 clinical trial design.
Current Projects of Interest
- Applications to PBAC, MSAC and the Prostheses list
- Global model for a new leading vaccine
- Model adaptations for Asia, Europe and the Americas. Illuminate is adapting a range of budget impact and economic models for a major multinational company. Several of these were developed by Illuminate and others by another UK based consultancy.